Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance

References 

1. Van Assche G, Magdelaine-Beuzelin C, D'Haens G, et al. Withdrawal of immunosuppression in Crohn's disease treated with scheduled infliximab maintenance: a randomized trial. Gastroenterology. 2008;134:1861–1868
   • Abstract
   • Full Text
   • Full-Text PDF (613 KB)
   • CrossRef
2. Cottone M, Rosselli M, Orlando A, et al. Smoking habits and recurrence in Crohn's disease. Gastroenterology. 1994;106:643–648
   • Abstract
3. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989;34:1841–1854
   • MEDLINE
   • CrossRef
4. Arnott DR, Mcneill G, Satsangi J. An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease. Aliment Pharmacol Ther. 2003;17:1451–1457
   • MEDLINE
   • CrossRef
5. Parsi MA, Achkar JP, Richardson S, et al. Predictors of response to infliximab in patients with Crohn's disease. Gastroenterology. 2002;123:707–713
   • Abstract
   • Full Text
   • Full-Text PDF (91 KB)
   • CrossRef
6. Cosnes J, Beaugerie L, Carbonnel F, et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology. 2001;120:1093–1099
   • Abstract
   • Full Text
   • Full-Text PDF (230 KB)
   • CrossRef
7. Sutherland LR, Ramcharan S, Bryant H, et al. Effects of cigarette smoking on recurrence of Crohn's disease. Gastroenterology. 1990;98:1123–1128
   • Abstract
   • Full-Text PDF (813 KB)
8. Ryan WR, Allan RN, Yamamoto T, et al. Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence. Am J Surg. 2004;187:219–225
   • Abstract
   • Full Text
   • Full-Text PDF (277 KB)
   • CrossRef